Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

81. Full-field digital mammography for breast cancer screening

Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Full-field digital mammography for breast cancer screening. Lansdale: HAYES, Inc.. Directory Publication. 2011 Authors' objectives Full (...) -field digital mammography (FFDM) is an alternative to conventional screen-film mammography (SFM), the standard of care for detecting breast cancer. With digital mammography, images of the breast are acquired, displayed, transferred, and stored as digital data for viewing on a computer monitor (soft-copy reading) or for printing and viewing with a light box (hard-copy reading). In contrast to SFM, FFDM simplifies image interpretation because image acquisition, image processing, image review, and data

2011 Health Technology Assessment (HTA) Database.

82. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. (PubMed)

Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. Women with a personal history of breast cancer (PHBC) are at risk of developing another breast cancer and are recommended for screening mammography. Few high-quality data exist on screening performance in PHBC women.To examine the accuracy and outcomes of mammography screening in PHBC women relative to screening of similar women without PHBC.Cohort of PHBC women, mammogram matched (...) to non-PHBC women, screened through facilities (1996-2007) affiliated with the Breast Cancer Surveillance Consortium.There were 58,870 screening mammograms in 19,078 women with a history of early-stage (in situ or stage I-II invasive) breast cancer and 58,870 matched (breast density, age group, mammography year, and registry) screening mammograms in 55,315 non-PHBC women.Mammography accuracy based on final assessment, cancer detection rate, interval cancer rate, and stage at diagnosis.Within 1 year

Full Text available with Trip Pro

2011 JAMA

83. The Efficacy of Breast Specific Gamma Imaging Over Mammography for Breast Cancer Screening in All Women.

The Efficacy of Breast Specific Gamma Imaging Over Mammography for Breast Cancer Screening in All Women. "The Efficacy of Breast Specific Gamma Imaging Over Mammography for Bre" by Tawny Schmeer < > > > > > Title Author Date of Graduation Winter 1-2011 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Dr. Torry Cobb Rights . Abstract Background: As the second most diagnosed cancer among women in the US, breast cancer has been, and continues (...) to be, a life threatening disease affecting thousands. Mammography has been the primary tool used in screening for breast cancer for decades, despite minimal advancement in the area of its main limitation, dense breast tissue. Recently gamma imaging has undergone significant improvements in the area of breast specific imaging and appears primed to address the needs of a population where mammography is insufficient. The purpose of this systematic review is to compare the efficacy of Breast Specific Gamma

2011 Pacific University EBM Capstone Project

84. Screening Mammography for Women Aged 40 to 49 Years at Average Risk for Breast Cancer

Screening Mammography for Women Aged 40 to 49 Years at Average Risk for Breast Cancer 1 OHTAC Recommendation Screening Mammography for Women Aged 40 to 49 Years at Average Risk for Breast Cancer Updated January 2011 This recommendation summary has been prepared by the Medical Advisory Secretariat of the Ministry of Health and Long Term Care on behalf of the Ontario Health Technology Advisory Committee. Presented to the Ontario Health Technology Advisory Committee in November, 2010 Issue (...) Background Breast cancer is a disease of aging with a four-fold higher incidence in women 50 to 69 years of age (500 per 100,000 women) compared to women 40 to 49 years of age (140 per 100,000 women). The estimated number of new breast cancer diagnoses in Ontario women 40 to 49 year of age is approximately 1,400 per year. There are approximately 1.02 million women in this age group in Ontario at present. The MAS review assessed the effectiveness of screening (film) mammography in women 40 to 49 years

2011 Health Quality Ontario

85. Comparative evaluation of digital mammography and film mammography: systematic review and meta-analysis

Comparative evaluation of digital mammography and film mammography: systematic review and meta-analysis Comparative evaluation of digital mammography and film mammography: systematic review and meta-analysis Comparative evaluation of digital mammography and film mammography: systematic review and meta-analysis Iared W, Shigueoka DC, Torloni MR, Velloni FG, Ajzen SA, Atallah AN, Valente O CRD summary This review concluded that cancer detection rates were slightly higher using digital mammography (...) than film mammography. Characteristics of tumours detected were similar and there were no significant differences in recall rates between film and digital mammography. These conclusions reflect the data, but should be interpreted cautiously, given limitations in the review process and analysis and small effect sizes. Authors' objectives To compare the performance of digital and film mammography for breast cancer screening. Searching MEDLINE, Scopus, EMBASE and LILACS were searched to September 2009

Full Text available with Trip Pro

2011 DARE.

86. Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review

Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

87. Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis

Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

88. Effect of screening mammography on breast-cancer mortality in Norway. (PubMed)

Effect of screening mammography on breast-cancer mortality in Norway. A challenge in quantifying the effect of screening mammography on breast-cancer mortality is to provide valid comparison groups. The use of historical control subjects does not take into account chronologic trends associated with advances in breast-cancer awareness and treatment.The Norwegian breast-cancer screening program was started in 1996 and expanded geographically during the subsequent 9 years. Women between the ages (...) of 50 and 69 years were offered screening mammography every 2 years. We compared the incidence-based rates of death from breast cancer in four groups: two groups of women who from 1996 through 2005 were living in counties with screening (screening group) or without screening (nonscreening group); and two historical-comparison groups that from 1986 through 1995 mirrored the current groups.We analyzed data from 40,075 women with breast cancer. The rate of death was reduced by 7.2 deaths per 100,000

2010 NEJM

89. Screening mammography - a long run for a short slide? (PubMed)

Screening mammography - a long run for a short slide? 20860510 2010 09 28 2016 11 25 1533-4406 363 13 2010 Sep 23 The New England journal of medicine N. Engl. J. Med. Screening mammography--a long run for a short slide? 1276-8 10.1056/NEJMe1008369 Welch H Gilbert HG eng Editorial Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2010 Sep 23;363(13):1203-10 20860502 N Engl J Med. 2011 Jan 20;364(3):284-5; author reply 286 21247319 Breast Neoplasms diagnostic imaging (...) mortality prevention & control Europe Female Humans Mammography Mass Screening United States 2010 9 24 6 0 2010 9 24 6 0 2010 9 30 6 0 ppublish 20860510 10.1056/NEJMe1008369

2010 NEJM

90. Breast cancer mortality in organised mammography screening in Denmark: comparative study. (PubMed)

Breast cancer mortality in organised mammography screening in Denmark: comparative study. To determine whether the previously observed 25% reduction in breast cancer mortality in Copenhagen following the introduction of mammography screening was indeed due to screening, by using an additional screening region and five years additional follow-up.We used Poisson regression analyses adjusted for changes in age distribution to compare the annual percentage change in breast cancer mortality in areas (...) where screening was used with the change in areas where it was not used during 10 years before screening was introduced and for 10 years after screening was in practice (starting five years after introduction of screening).Copenhagen, where mammography screening started in 1991, and Funen county, where screening was introduced in 1993. The rest of Denmark (about 80% of the population) served as an unscreened control group.All Danish women recorded in the Cause of Death Register and Statistics

Full Text available with Trip Pro

2010 BMJ

91. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of screening for breast cancer, using magnetic resonance imaging (MRI), screen-film mammography, or both, for women with mutations of the breast cancer gene BRCA1. The authors concluded that annual mammography and MRI detected

Full Text available with Trip Pro

2010 NHS Economic Evaluation Database.

92. Randomised controlled trial: A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women

Randomised controlled trial: A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women | Evidence-Based Nursing We use cookies to improve our service and to tailor (...) name or password? You are here A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women Article Text Therapeutics Randomised controlled trial A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women Maggi Banning Statistics

2010 Evidence-Based Nursing

93. Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis

Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

94. Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF.

Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. – Clinical Correlations Search Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. November 17, 2009 2 min read Aalok Turakhia, MD As the debate over when to begin screening mammography in women rages on, the United States Prevention Service Task Force (USPSTF) added fuel to the fire by releasing a new recommendation statement (...) in the November 17th issue of the Annals of Internal Medicine. Applying to women aged ≥40 who are not at an increased genetic risk or have had chest irradiation, the USPSTF now recommends biennial screening in women between ages 50-74. In February 2002, the task force first recommended that annual or biennial screening start at age 40; however, in a revised statement, “The USPSTF recommends against routine screening mammography in women aged 40 to 49 years.” It adds, “The decision to start regular, biennial

2009 Clinical Correlations

95. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms. (PubMed)

Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms. Despite trials of mammography and widespread use, optimal screening policy is controversial.To evaluate U.S. breast cancer screening strategies.6 models using common data elements.National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects.A contemporary population cohort.Lifetime.Societal.20 screening strategies with varying

Full Text available with Trip Pro

2009 Annals of Internal Medicine

96. A meta-analysis of interventions to promote mammography among ethnic minority women (PubMed)

A meta-analysis of interventions to promote mammography among ethnic minority women Although many studies have been focused on interventions designed to promote mammography screening among ethnic minority women, few summaries of the effectiveness of the interventions are available.The aim of this study was to determine the effectiveness of the interventions for improving mammography screening among asymptomatic ethnic minority women.A meta-analysis was performed on intervention studies designed (...) to promote mammography use in samples of ethnic minority women. Random-effects estimates were calculated for interventions by measuring differences in intervention and control group screening rates postintervention.The overall mean weighted effect size for the 23 studies was 0.078 (Z = 4.414, p < .001), indicating that the interventions were effective in improving mammography use among ethnic minority women. For mammography intervention types, access-enhancing strategies had the biggest mean weighted

Full Text available with Trip Pro

2009 EvidenceUpdates

97. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. (PubMed)

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. To estimate the extent of overdiagnosis (the detection of cancers that will not cause death or symptoms) in publicly organised screening programmes.Systematic review of published trends in incidence of breast cancer before and after the introduction of mammography screening.PubMed (April 2007), reference lists, and authors. Review methods One author extracted data on incidence of breast

Full Text available with Trip Pro

2009 BMJ

98. Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data (PubMed)

Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data To (a) compare the performance of full-field digital mammography (FFDM), using hard-copy image reading, with that of screen-film mammography (SFM) within a UK screening program (screening once every 3 years) for women aged 50 years or older and (b) conduct a meta-analysis of published findings along with the UK data.The study complied with the UK National

Full Text available with Trip Pro

2009 EvidenceUpdates

99. Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data

Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data Vinnicombe S, Pinto Pereira SM, McCormack VA, Shiel S, Perry N, dos Santos (...) Silva IM CRD summary This review concluded that within a routine screening programme, full-field digital mammography with hard-copy reading performed at least as well as screen-film mammography for breast cancer detection. Multiple issues with the methodology and reporting of the review process mean that the reliability of these conclusions is unclear. Authors' objectives To compare full-field digital mammography using hard-copy image reading with screen-film mammography within a three-yearly

Full Text available with Trip Pro

2009 DARE.

100. [Diagnostic performance of digital mammography in breast cancer screening]

[Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Marquez Cruz MD, Marquez Calderon S Record Status This is a bibliographic record of a published health (...) technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Marquez Cruz MD, Marquez Calderon S. Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama. [Diagnostic performance of digital mammography in breast cancer screening] Seville: Andalusian Agency for Health Technology Assessment (AETSA). Informes de Evaluacion de Tecnologias Sanitarias AETSA 2007/09. 2009 Authors' conclusions No important

2009 Health Technology Assessment (HTA) Database.